Johnson Chemical Pharmaceutical Works Co., Ltd. (4747) Stock Statistics & Valuation Metrics

Johnson Chemical Pharmaceutical Works Co., Ltd. has a market cap or net worth of TWD 1.96B. The enterprise value is TWD 2.60B.

Market Cap

TWD 1.96B

Enterprise Value

TWD 2.60B

Johnson Chemical Pharmaceutical Works Co., Ltd. has 90,922,066 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

90,922,066

Owned by Insiders

―

Owned by Institutions

0.01%

Johnson Chemical Pharmaceutical Works Co., Ltd.’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 3.14%.

Return on Equity (ROE)

0.03

Return on Assets (ROA)

0.03

Return on Invested Capital (ROIC)

3.14%

Return on Capital Employed (ROCE)

0.04

Revenue Per Employee

3.03M

Profits Per Employee

284.60K

Employee Count

188

Asset Turnover

0.27

Inventory Turnover

1.81

The current PE Ratio of Johnson Chemical Pharmaceutical Works Co., Ltd. is 17.69. Johnson Chemical Pharmaceutical Works Co., Ltd.’s PEG ratio is 2.01.

PE Ratio

17.69

PS Ratio

2.76

PB Ratio

0.91

Price to FCF

-39.04

Price to Operating Cash Flow

65.19

PEG Ratio

2.01

In the last 12 months, Johnson Chemical Pharmaceutical Works Co., Ltd. had revenue of 569.77M and earned 53.51M in profits. Earnings per share was 0.59.

Revenue

569.77M

Gross Profit

228.35M

Operating Income

73.33M

Pretax Income

63.38M

Net Income

53.51M

EBITDA

93.67M

Earnings Per Share (EPS)

0.59

In the last 12 months, operating cash flow was 24.29M and capital expenditures -65.16M, giving a free cash flow of -40.87M billion.

Operating Cash Flow

24.29M

Free Cash Flow

-40.87M

Free Cash Flow per Share

-0.45

Johnson Chemical Pharmaceutical Works Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of 2.43%

Dividend Per Share

―

Dividend Yield

2.43%

Payout Ratio

N/A

Free Cash Flow Yield

-2.31%

Earnings Yield

5.09%

Beta

0.19

52-Week Price Change

-35.62%

50-Day Moving Average

23.67

200-Day Moving Average

25.88

Relative Strength Index (RSI)

29.35

Average Volume (3m)

74.75K

Johnson Chemical Pharmaceutical Works Co., Ltd. upcoming earnings date is ―, TBA (Confirmed).

Last Earnings Date

Aug 14, 2026

Next Earnings Date

―

Ex-Dividend Date

―

Johnson Chemical Pharmaceutical Works Co., Ltd. as a current ratio of 3.79, with Debt / Equity ratio of 15.27%

Current Ratio

3.79

Quick Ratio

3.30

Debt to Market Cap

0.10

Net Debt to EBITDA

-8.42

Interest Coverage Ratio

19.58

In the past 12 months, Johnson Chemical Pharmaceutical Works Co., Ltd. has paid 9.87M in taxes.

Income Tax

9.87M

Effective Tax Rate

0.16

Johnson Chemical Pharmaceutical Works Co., Ltd. EV to EBITDA ratio is 26.69, with an EV/FCF ratio of -52.65.

EV to Sales

3.72

EV to EBITDA

26.69

EV to Free Cash Flow

-52.65

EV to Operating Cash Flow

88.59

Johnson Chemical Pharmaceutical Works Co., Ltd. has TWD 261.73M in cash and marketable securities with TWD 645.00M in debt, giving a net cash position of -TWD 383.27M billion.

Cash & Marketable Securities

TWD 261.73M

Total Debt

TWD 645.00M

Net Cash

-TWD 383.27M

Net Cash Per Share

-TWD 4.22

Tangible Book Value Per Share

TWD 19.27

Gross margin is 39.30%, with operating margin of 10.16%, and net profit margin of 15.47%.

Gross Margin

39.30%

Operating Margin

10.16%

Pretax Margin

16.21%

Net Profit Margin

15.47%

EBITDA Margin

13.95%

EBIT Margin

11.31%

The average price target for Johnson Chemical Pharmaceutical Works Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

4.56%

EPS Growth Forecast

-172.55%